SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 7/26/16 Dupont E I De Nemours & Co 10-Q 6/30/16 83:10M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 680K 2: EX-10.6 Material Contract HTML 117K 3: EX-12 Statement re: Computation of Ratios HTML 32K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 26K 14: R1 Document and Entity Information HTML 43K 15: R2 Consolidated Income Statements HTML 89K 16: R3 Consolidated Statements of Comprehensive Income HTML 90K 17: R4 Condensed Consolidated Balance Sheets HTML 118K 18: R5 Condensed Consolidated Balance Sheets HTML 36K (Parenthetical) 19: R6 Condensed Consolidated Statements of Cash Flows HTML 106K 20: R7 Summary of Significant Accounting Policies HTML 40K 21: R8 Proposed Merger with Dow Chemical HTML 30K 22: R9 Divestitures and Other Transactions HTML 76K 23: R10 Employee Separation / Asset Related Charges, Net HTML 79K 24: R11 Other Income, Net HTML 85K 25: R12 Provision for Income Taxes HTML 29K 26: R13 Earnings Per Share of Common Stock HTML 68K 27: R14 Inventories HTML 36K 28: R15 Other Intangible Assets HTML 80K 29: R16 Short-Term and Long-Term Borrowings HTML 33K 30: R17 Commitments and Contingent Liabilities HTML 81K 31: R18 Stockholders' Equity HTML 272K 32: R19 Financial Instruments HTML 202K 33: R20 Long-Term Employee Benefits HTML 86K 34: R21 Segment Information HTML 156K 35: R22 Summary of Significant Accounting Policies Summary HTML 40K of Significant Accounting Policies (Policies) 36: R23 Divestitures and Other Transactions Divestitures HTML 67K and Other Transactions (Tables) 37: R24 Employee Separation / Asset Related Charges, Net HTML 74K (Tables) 38: R25 Other Income, Net (Tables) HTML 86K 39: R26 Earnings Per Share of Common Stock (Tables) HTML 68K 40: R27 Inventories (Tables) HTML 35K 41: R28 Other Intangible Assets (Tables) HTML 76K 42: R29 Commitments and Contingent Liabilities (Tables) HTML 52K 43: R30 Stockholders' Equity (Tables) HTML 262K 44: R31 Financial Instruments (Tables) HTML 188K 45: R32 Long-Term Employee Benefits (Tables) HTML 81K 46: R33 Segment Information (Tables) HTML 155K 47: R34 Summary of Significant Accounting Policies Recent HTML 32K Accounting Pronouncements (Details) 48: R35 Proposed Merger with Dow Chemical (Narrative) HTML 25K (Details) 49: R36 Divestitures and Other Transactions (Narrative) HTML 88K (Details) 50: R37 Divestitures and Other Transactions (Schedule of HTML 59K results of operations from discontinued operations) (Details) 51: R38 Divestitures and Other Transactions (Schedule of HTML 31K cash flow information of discontinued operations) (Details) 52: R39 Employee Separation / Asset Related Charges, Net HTML 35K (La Porte) (Narrative) (Details) 53: R40 Employee Separation / Asset Related Charges, Net HTML 71K (2016 Restructuring Program schedule )(Details) 54: R41 Employee Separation / Asset Related Charges, Net HTML 56K (2014 Restructuring Program schedule) (Details) 55: R42 Employee Separation / Asset Related Charges, Net HTML 34K (Narrative) (Details) 56: R43 Other Income, Net (Schedule of Other Income) HTML 57K (Details) 57: R44 Other Income, Net (Schedule of Foreign Exchange HTML 39K Gain (Loss)) (Details) 58: R45 Provision for Income Taxes (Details) HTML 29K 59: R46 Earnings Per Share of Common Stock (Earnings Per HTML 49K Share of Common Stock Reconciliation) (Details) 60: R47 Earnings Per Share of Common Stock (Schedule of HTML 30K Average Number of Antidilutive Stock Options) (Details) 61: R48 Inventories (Details) HTML 37K 62: R49 Other Intangible Assets (Schedule of Other HTML 66K Intangible Assets) (Details) 63: R50 Other Intangible Assets (Narrative) (Details) HTML 45K 64: R51 Short-Term and Long-Term Borrowings (Details) HTML 73K 65: R52 Commitments and Contingent Liabilities HTML 56K (Guarantees) (Details) 66: R53 Commitments and Contingent Liabilities HTML 95K (Litigation) (Narrative) (Details) 67: R54 Commitments and Contingent Liabilities HTML 38K (Environmental) (Narrative) (Details) 68: R55 Stockholders' Equity (Share Repurchase Program) HTML 50K (Narrative) (Details) 69: R56 Stockholders' Equity (Schedule of Other HTML 191K Comprehensive Income) (Details) 70: R57 Stockholder's Equity (Schedule of Accumulated HTML 76K Other Comprehensive Loss) (Details) 71: R58 Financial Instruments (Schedule of Cash, Cash HTML 65K Equivalents and Marketable Securities) (Details) 72: R59 Financial Instruments (Debt) (Narrative) (Details) HTML 26K 73: R60 Financial Instruments (Notional Amounts of HTML 34K Derivatives) (Details) 74: R61 Financial Instruments (Effect of Cash Flows Hedges HTML 37K on Accumulated Other Comprehensive Income (Loss)) (Details) 75: R62 Financial Instruments (Schedule of the Fair Value HTML 52K of Derivative Instruments) (Details) 76: R63 Financial Instruments (Effect of Derivative HTML 70K Instruments) (Details) 77: R64 Long-Term Employee Benefits (Schedules of Net HTML 76K Periodic Benefit Cost) (Details) 78: R65 Segment Information (Schedule of Segment HTML 50K Information) (Details) 79: R66 Segment Information (Reconciliation to HTML 77K Consolidated Income Statements) (Details) 80: R67 Segment Information (Schedule of Additional HTML 125K Segment Information) (Details) 82: XML IDEA XML File -- Filing Summary XML 151K 81: EXCEL IDEA Workbook of Financial Reports XLSX 99K 8: EX-101.INS XBRL Instance -- dd-20160630 XML 3.96M 10: EX-101.CAL XBRL Calculations -- dd-20160630_cal XML 258K 11: EX-101.DEF XBRL Definitions -- dd-20160630_def XML 1.05M 12: EX-101.LAB XBRL Labels -- dd-20160630_lab XML 1.84M 13: EX-101.PRE XBRL Presentations -- dd-20160630_pre XML 1.15M 9: EX-101.SCH XBRL Schema -- dd-20160630 XSD 217K 83: ZIP XBRL Zipped Folder -- 0000030554-16-000147-xbrl Zip 316K
Exhibit |
1. | I have reviewed this report on Form 10-Q for the period ended June 30, 2016 of E. I. du Pont de Nemours and Company; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | |
By: | /s/ Edward D. Breen |
Chair of the Board and | |
Chief
Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 7/26/16 | 8-K | ||
For Period end: | 6/30/16 | 4 | ||
List all Filings |